124 related articles for article (PubMed ID: 26652134)
21. Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.
Su JM; Gui L; Zhou YP; Zha XL
World J Gastroenterol; 2002 Aug; 8(4):613-8. PubMed ID: 12174366
[TBL] [Abstract][Full Text] [Related]
22. Expression of beta1-integrins and N-cadherin in bladder cancer and melanoma cell lines.
Laidler P; Gil D; Pituch-Noworolska A; Ciołczyk D; Ksiazek D; Przybyło M; Lityńska A
Acta Biochim Pol; 2000; 47(4):1159-70. PubMed ID: 11996105
[TBL] [Abstract][Full Text] [Related]
23. Expression and role of E-cadherin and CD103beta7 (alphaEbeta7 integrin) on cultured mucosal-type mast cells.
Tegoshi T; Nishida M; Arizono N
APMIS; 2005 Feb; 113(2):91-8. PubMed ID: 15723683
[TBL] [Abstract][Full Text] [Related]
24. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.
Nam EH; Lee Y; Zhao XF; Park YK; Lee JW; Kim S
Carcinogenesis; 2014 Feb; 35(2):302-14. PubMed ID: 24130169
[TBL] [Abstract][Full Text] [Related]
25. Differential immunohistochemical expression of CD44s, E-cadherin and β-catenin among hyperplastic and neoplastic lesions of the prostate gland.
Lazari P; Poulias H; Gakiopoulou H; Thomopoulou GH; Barbatis C; Lazaris AC
Urol Int; 2013; 90(1):109-16. PubMed ID: 23220849
[TBL] [Abstract][Full Text] [Related]
26. An inverse relation between COX-2 and E-cadherin expression correlates with aggressive histologic features in prostate cancer.
Rao DS; Gui D; Koski ME; Popoviciu LM; Wang H; Reiter RE; Said JW
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):375-83. PubMed ID: 17122632
[TBL] [Abstract][Full Text] [Related]
27. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
[TBL] [Abstract][Full Text] [Related]
28. Alterations of C-MYC, NKX3.1, and E-cadherin expression in canine prostate carcinogenesis.
Fonseca-Alves CE; Rodrigues MM; de Moura VM; Rogatto SR; Laufer-Amorim R
Microsc Res Tech; 2013 Dec; 76(12):1250-6. PubMed ID: 24030851
[TBL] [Abstract][Full Text] [Related]
29. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
[TBL] [Abstract][Full Text] [Related]
30. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
[TBL] [Abstract][Full Text] [Related]
31. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.
Engl T; Relja B; Marian D; Blumenberg C; Müller I; Beecken WD; Jones J; Ringel EM; Bereiter-Hahn J; Jonas D; Blaheta RA
Neoplasia; 2006 Apr; 8(4):290-301. PubMed ID: 16756721
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement.
Isebaert S; Haustermans K; Van den Bergh L; Joniau S; Dirix P; Oyen R; Deroose CM; Van Poppel H; Lerut E
Acta Oncol; 2013 Oct; 52(7):1336-44. PubMed ID: 23879650
[TBL] [Abstract][Full Text] [Related]
33. Relationship between LSD1 expression and E-cadherin expression in prostate cancer.
Wang M; Liu X; Jiang G; Chen H; Guo J; Weng X
Int Urol Nephrol; 2015 Mar; 47(3):485-90. PubMed ID: 25627913
[TBL] [Abstract][Full Text] [Related]
34. The role of alpha E beta 7 integrin (CD103) and E-cadherin in epidermotropism in cutaneous T-cell lymphoma.
Dietz SB; Whitaker-Menezes D; Lessin SR
J Cutan Pathol; 1996 Aug; 23(4):312-8. PubMed ID: 8864917
[TBL] [Abstract][Full Text] [Related]
35. Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer.
Yamamichi F; Shigemura K; Behnsawy HM; Meligy FY; Huang WC; Li X; Yamanaka K; Hanioka K; Miyake H; Tanaka K; Kawabata M; Shirakawa T; Fujisawa M
Scand J Urol; 2014 Dec; 48(6):523-32. PubMed ID: 25356787
[TBL] [Abstract][Full Text] [Related]
36. Cadherins and integrins in renal cell carcinoma: an immunohistochemical study.
Markovic-Lipkovski J; Brasanac D; Müller GA; Müller CA
Tumori; 2001; 87(3):173-8. PubMed ID: 11504373
[TBL] [Abstract][Full Text] [Related]
37. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
Kuniyasu H; Troncoso P; Johnston D; Bucana CD; Tahara E; Fidler IJ; Pettaway CA
Clin Cancer Res; 2000 Jun; 6(6):2295-308. PubMed ID: 10873080
[TBL] [Abstract][Full Text] [Related]
38. N-cadherin increases after androgen deprivation and is associated with metastasis in prostate cancer.
Jennbacken K; Tesan T; Wang W; Gustavsson H; Damber JE; Welén K
Endocr Relat Cancer; 2010 Jun; 17(2):469-79. PubMed ID: 20233707
[TBL] [Abstract][Full Text] [Related]
39. E-cadherin expression in prostate adenocarcinomas in Chinese and its pathological correlates.
Hsu YS; Wang JS; Wu TT
Urol Int; 2004; 73(1):36-40. PubMed ID: 15263791
[TBL] [Abstract][Full Text] [Related]
40. [Expression and significance of metastasis-associated proteins in prostate cancer cell lines with different metastatic potentials].
Luo Y; He DL; Ning L; Zhu GD; Shen SL
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):230-3. PubMed ID: 16597039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
